Journal Article

DKFZ-2025-01909

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Targeting BCMA in CIDP: Valuable insights gained through multi-omics immune monitoring.

Funk, M. A.DKFZ* ; Theurich, S.DKFZ*

2025
Elsevier Amsterdam

This record in other databases:

Please use a persistent id in citations: doi:10.1016/j.medj.2025.100753

Abstract: Dong et al. present two patients with refractory chronic inflammatory demyelinating polyneuropathy (CIDP), who received treatment with B-cell-maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR)-T cells.1 Extensive concomitant immune monitoring provides insights into the pathogenesis and mechanisms of relapse in CIDP that may help to determine the role of BCMA-targeted CAR-T cell therapy for this disease in the future.

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle München (MU01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025

---

Database coverage:
; Clarivate Analytics Master Journal List ; Emerging Sources Citation Index ; IF >= 15 ; JCR ; SCOPUS ; Web of Science Core Collection

---